Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TORONTO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Captor Capital Corp. (“Captor” or the “Company”) (CSE:CPTR; USOTC:NWURF; FRANKFURT:NMV) today announced that I-5 Holdings CEO John MacPhail will be...
-
VANCOUVER, B.C. and BOSTON, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) today reported financial results...
-
Gesamtumsatz um 30 % auf CHF 59.9 Mio. gesteigert, Ausblick für Gesamtumsatz 2018 auf CHF 120 - 130 Mio. erhöht Lizenzgebühren (Royalties) auf Cresemba-Umsätze auf CHF 10.8 Mio. mehr als...
-
Total revenue increased by 30% to CHF 59.9 million; 2018 total revenue guidance is increased to CHF 120 - 130 million Royalties on Cresemba sales more than doubled to CHF 10.8 million Clinical...
-
Basel, 13. August 2018 - Basilea Pharmaceutica AG (SIX: BSLN) gab heute bekannt, dass ihr Partner Hikma Pharmaceuticals LLC die Zulassung für das Antimykotikum Cresemba® (Isavuconazol) in Jordanien...
-
Basel, Switzerland, August 13, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its partner Hikma Pharmaceuticals LLC, gained regulatory approval for the antifungal Cresemba®...
-
TORONTO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Captor Capital Corp. (“Captor” or the “Company”) (CSE:CPTR; USOTC:NWURF FRANKFURT:NMV) The company is pleased to announce an updated shareholder...
-
Basel, 09. August 2018 - Basilea Pharmaceutica AG (SIX: BSLN) gab heute den Beginn einer Phase-3-Studie mit ihrem Antibiotikum Ceftobiprol bekannt. In der zulassungsrelevanten Studie wird die...
-
Basel, Switzerland, August 09, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today the start of a clinical phase 3 study with its antibiotic ceftobiprole. The registration study evaluates...
-
TORONTO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Captor Capital Corp. (“Captor” or the “Company”) (CSE:CPTR; USOTC:NWURF FRANKFURT:NMV) today resumed trading on the Canadian Securities Exchange as a...